Department of Pharmaceutical Policy, Central European Health University, Brno, Czech Republic
Brief Report
Valuing High-cost Specialty Drugs: A New Era
Author(s): Stefan Novak*
DOI:
10.37421/2472-1042.2025.10.312
Pharmacoeconomics: Open Access received 106 citations as per Google Scholar report